Dofetilide
39 NDCs across 12 manufacturers|33 Generic,6 Brand
Dofetilide is used to treat atrial fibrillation and atrial flutter, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 1, 1999, and the first generic was approved Jun 6, 2016. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $68 million on Dofetilide across 336,000 claims for 75,000 beneficiaries.
Dofetilide is available as 39 NDCs from 12 manufacturers (33 generic, 6 brand), with NADAC prices from $0.19 to $10.77 per EA — the most expensive product costs about 58× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
39
33G / 6B
Manufacturers
12
competing in market
Price Spread
$0.19 – $10.77
per EA
7d Activity
avg +1.1% WoW · of 39 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pfizer Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Antiarrhythmic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
12 manufacturers producing DOFETILIDE(5 pricing outliers)
Frequently Asked Questions
What is Dofetilide used to treat?
Dofetilide is used to treat atrial fibrillation and atrial flutter, per the National Library of Medicine's MED-RT classification.
When did Dofetilide become available as a generic?
FDA approved the first generic Dofetilide (ANDA) on Jun 6, 2016. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dofetilide?
In 2024, Medicare Part D spent $68 million on Dofetilide across 336,000 claims for 75,000 beneficiaries.
How many Dofetilide products are on the market?
The Dofetilide drug market contains 39 NDCs from 12 manufacturers — 33 generic and 6 brand products.
What is the price range for Dofetilide?
NADAC reference prices for Dofetilide range from $0.1864 to $10.7711 per EA — the most expensive product costs about 58× the cheapest.
Is generic Dofetilide cheaper than brand?
The average generic NADAC for Dofetilide is $0.1991 per EA, versus $10.1789 for brand-labeled products — brand versions average about 51× the generic price.
Which manufacturers make Dofetilide?
12 manufacturers list Dofetilide in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (6), Major Pharmaceuticals (4), Accord Healthcare Inc. (3), Sigmapharm Laboratories LLC (3), Bionpharma Inc. (3).
How has the price of Dofetilide changed recently?
Over the past 7 days, 25 Dofetilide NDCs rose and 0 fell, with a market-wide average change of +1.1%.